MEDIA RELEASE PR40795
Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market
JERUSALEM and NEEDHAM, Massachusetts, Aug. 18 /PRNewswire-AsiaNet/ --
Oridion (SIX Swiss Exchange: ORIDN), creator of the Smart
Capnography(TM) family of algorithm-based solutions (Integrated Pulmonary
Index(TM), SARA(TM), and Smart Breath Detection Algorithm(TM)), announced the
signing of a new agreement with IMI Co. Ltd., a leading distributor of
medical equipment in Japan. This agreement provides Oridion with the
opportunity to further expand into the Japanese market with its line of
Microstream(R) capnography monitoring products.
IMI will bundle sales of Capnostream(R)20 Smart Capnography
monitors including IPI* with their ventilators. This powerful combination
will be offered as SafetySet(TM), an innovative solution to improve patient
safety and make a clinical difference in patient care. IMI will begin selling
the Capnostream(R)20 monitors and patented FilterLine(R) etCO2 sampling
products immediately into the Critical Care environment and Home Care areas
throughout Japan.
Mr. Kazumasa Tsumuga, President of IMI, said: "We are happy to
join with Oridion to make available the best capnography technology to our
hospital markets in Japan. We believe the collaboration between IMI and
Oridion will help improve the safety for all the patient populations in all
clinical settings in Japan."
Gerry Feldman, President of Oridion Capnography Inc., remarks,
"We are honored to be working with IMI. The SafetySet package combining
Capnostream capnography with ventilators sold by IMI is a pioneering strategy
that will provide added safety for patients in hospitals throughout Japan.
Oridion is committed to improving the standard of healthcare worldwide and
will continue to offer new ways to improve patient safety and make a clinical
difference in patient care."
*IPI helps caregivers manage complicated monitoring parameters with a
single, simple number. The IPI utilizes real time measures and interactions
of four parameters - exhaled carbon dioxide (etCO2), respiration rate, pulse
rate, and oxygenation (SpO2) - to provide a single indexed value, enabling
clinicians to instantly assess the patient's respiratory status.
SARA (Smart Alarm Respiratory Analysis) is an alarm management algorithm
that, together with the Smart Breath Detection Algorithm, recognizes and
reduces clinically insignificant alarms while accurately reflecting the
patient's condition and preserving caregiver alarm vigilance.
About Oridion
device company specializing in patient safety monitoring. The Company
operates through wholly owned subsidiaries in the United States and Israel.
Oridion develops proprietary medical devices and patient interfaces,
based on its patented Microstream(R) technologies, for the enhancement of
patient safety through the monitoring of the carbon dioxide (CO2) in a
patient's breath. These products provide effective, proven airway management
and are used in various clinical environments, including procedural sedation,
pain management, critical care units, post-anesthesia care units, emergency
medical services, transport, alternate care and other settings where
patients' ventilation may be compromised and at risk.
Certain statements made herein that are not historical are
forward-looking. The words "estimate" "project" "intend" "expect" "believe"
and similar expressions are intended to identify forward-looking statements.
These forward-looking statements involve known and unknown risks and
uncertainties. Many factors could cause the actual results, performance or
achievements of the Company to be materially different from any future
results, performance or achievements that may be expressed or implied by such
forward-looking statements, including, among others, our ability to maintain
profits, the market demands for our Capnography products, our ability to
focus our team on the Capnography business, changes in general economic and
business conditions, inability to maintain market acceptance to the Company's
products, inability to timely develop and introduce new technologies,
products and applications, rapid changes in the market for the Company's
products, loss of market share and pressure on prices resulting from
competition, introduction of competing products by other companies, inability
to manage growth and expansion, loss of key OEM partners, inability to
attract and retain qualified personnel, inability to protect the Company's
proprietary technology. The Company does not assure any obligation to update
the forward-looking information contained in this press release.
For further Oridion information please contact:
Alan Adler, Chairman and Chief Executive Officer
Walter Tabachnik, Chief Financial Officer
Elena Gerberg, Investor Relations
e-mail: info@oridion.com
phone: +972-2-589-9159
address: Oridion Systems Ltd., P.O. Box 45025, 91450 Jerusalem, Israel
SOURCE: Oridion Systems Ltd.
Translations:
To view this and other AsiaNet releases please visit http://www.asianetnews.net
NEWS 
